Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2021
Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen TherapyMark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
Journal of Global Oncology|September 11, 2018
Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian PopulationPedro Isaacsson Velho, Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, et al.
Pathology Oncology Research : POR|June 26, 2020
Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell CarcinomaGuilherme Nader Marta, Pedro Isaacsson Velho, Renata R C Bonadio, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 10, 2024
Latin American Challenges and Recommendations for Poly Adenosine Diphosphate Ribose Polymerase Inhibitor Treatment in Metastatic Castration Resistant Prostate Cancer: An Expert OverviewRodolfo Borges Dos Reis, José L Aguilar-Ponce, Federico Cayol, et al.
The Prostate|July 31, 2019
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancerChanning J Paller, Danilo Piana, James R Eshleman, et al.
Ecancermedicalscience|January 11, 2020
Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?Renata Colombo Bonadioa, Pedro Isaacsson Velho, Guilherme Nader Marta, et al.
European Urology|October 9, 2018
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene DefectsPedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2020
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancerMaarten J van der Doelen, Pedro Isaacsson Velho, Peter H J Slootbeek, et al.
European Urology|July 7, 2020
Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate CancerUmang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al.
European Urology|June 10, 2019
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate CancerPedro Isaacsson Velho, Wei Fu, Hao Wang, et al.
Pageof 4